TG Therapeutics, Inc. (NASDAQ: TGTX) shares are trading higher after the company reported preliminary fiscal-year 2025 total global revenue results on Tuesday after the market closed. TG Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results